logo

For the Inventor, By the Inventor

Milan, Italy

Franco Zunino

This inventor holds 17 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignees: Sigma-Tau Industrie Farmaceutiche Riunite S.p.a., Istituto Nazionale Per Lo Studio E La Cura Dei Tumori, Boehringer Biochemia Robin S.p.a.. Active years: 1988-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Franco Zunino. Retrieved from https://idiyas.com/inventor/franco-zunino

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 

% Patents Active = 41.2


Average Co-Inventor Count = 4.9

ph-index = 4

Forward Citations = 72(Granted Patents)


Company Filing History:

goldMedal11 out of 343 
 
Sigma-Tau Industrie Farmaceutiche Riunite S.p.a.
 patents
silverMedal5 out of 14 
 
Istituto Nazionale Per Lo Studio E La Cura Dei Tumori
 patents
bronzeMedal2 out of 22 
 
Boehringer Biochemia Robin S.p.a.
 patents
4. 1 out of 27 
 
Boehringer Mannheim Italia
 patents
5. 1 out of 3 
 
Instituto Nazionale Per Lo Studio E La Cura Dei Tumori
 patents
6. 1 out of 1 
 
Istituo Nazionale Per Lo Studio E La Cura Dei Tumori
 patent
7. 1 out of 1 
 
Istituto Nazional Per Lo Studio E La Cura Dei Tumori
 patent
8. 1 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 1988-2014

Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents
1. 8853233 - Broad-spectrum anti-cancer treatment based on iminocamptothecin derivatives (2014-10-07),
2. 8053460 - Indole derivatives having antitumor activity (2011-11-08),
3. 7816386 - Cinnamic, phenylpropiolic and phenylpropanoic acid derivatives useful as anti-tumor agents (2010-10-19),
4. 7728039 - Biphenyl and Naphthyl-Phenyl Hydroxamic Acid Derivatives (2010-06-01),
5. 7705012 - Camptothecins conjugated in position 7 to cyclic peptides as cytostatic agents (2010-04-27),
6. 7612081 - 7-Polyaminoalkyl(oxy)iminomethylcamptothecins bearing protective groups (2009-11-03),
7. 7589099 - 7-t-butoxyiminomethylcamptothecin conjugated in position 20 with integrin antagonists (2009-09-15),
8. 7498340 - Esters in position 20 of camptothecins (2009-03-03),
9. 7351714 - 7-imino derivatives of camptothecin having antitumor activity (2008-04-01),
10. 7105492 - Camptothecin derivatives having antitumor activity (2006-09-12),
11. 6589939 - Camptothecin derivatives having antitumor activity (2003-07-08),
12. 6306868 - Methods for inhibiting the growth of tumors with 7-substituted camptothecin derivatives (2001-10-23),
13. 6242457 - Camptothecin derivatives having antitumor activity (2001-06-05),
14. 6130227 - 7-Substituted camptothecin derivatives and methods for inhibiting the (2000-10-10),
15. 5145848 - Amino anthracenediones-bis platinum complexes, useful as antitumoral (1992-09-08),

Title: Franco Zunino: Innovator in Cancer Treatment

Introduction

Franco Zunino is a prominent inventor based in Milan, Italy, known for his significant contributions to cancer treatment through innovative pharmaceutical developments. With a total of 17 patents to his name, Zunino has made remarkable strides in the field of oncology.

Latest Patents

Zunino's latest patents include a broad-spectrum anti-cancer treatment based on iminocamptothecin derivatives. This subclass of camptothecin derivatives is disclosed to be useful for the preparation of a medicament for the treatment of various cancer pathologies, including head and neck carcinoma, pancreas carcinoma, melanoma, bladder carcinoma, mesothelioma, and epidermoid skin carcinoma. Another notable patent involves indole derivatives having antitumor activity. These indole derivatives of Formula (I+A) exhibit antitumor and chemosensitizing activity, and pharmaceutical compositions containing these compounds are described for the treatment of tumors.

Career Highlights

Throughout his career, Zunino has worked with esteemed organizations such as Sigma-Tau Industrie Farmaceutiche Riunite S.p.a. and the Istituto Nazionale Per Lo Studio E La Cura Dei Tumori. His work in these institutions has significantly advanced the understanding and treatment of cancer.

Collaborations

Zunino has collaborated with notable professionals in the field, including Sergio Penco and Claudio Pisano. These collaborations have further enriched his research and development efforts.

Conclusion

Franco Zunino's innovative work in cancer treatment exemplifies the impact of dedicated inventors in the medical field. His contributions continue to pave the way for advancements in oncology and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…